Prognostic factors after combined modality treatment of squamous cell carcinoma of the esophagus

Journal of Thoracic Oncology

Volumn 2, Issue 12, 2007, Pages 1117-1123

  Rizk, Nabil P ^a   Seshan, Venkatraman E ^b   Bains, Manjit S ^a   Ilson, David H ^a   Minsky, Bruce D ^a   Tang, Laura ^a   Rusch, Valerie W ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Chemoradiation; Esophageal squamous cell cancer; Prognostic variables

Indexed keywords

CISPLATIN; FLUOROURACIL; IRINOTECAN; PACLITAXEL;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS RESECTION; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; MINIMAL RESIDUAL DISEASE; MULTIMODALITY CANCER THERAPY; PREOPERATIVE RADIOTHERAPY; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; STATISTICAL ANALYSIS; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME;

EID: 37349015194     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e31815bfe53     Document Type: Article

References (29)

1. Heath EI, Burtness BA, Heitmiller RF, et al. Phase II evaluation of preoperative chemoradiation and postoperative adjuvant chemotherapy for squamous cell and adenocarcinoma of the esophagus. J Clin Oncol 2000;18:868-876.
2. Urba SG, Orringer MB, Turrisi A, et al. Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol 2001;19:305-313.
3. Burmeister BH, Smithers BM, Gebski V, et al. Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial. Lancet Oncol 2005;6:659-668.
4. Donington JS, Miller DL, Allen MS, et al. Preoperative chemoradiation therapy does not improve early survival after esophagectomy for patients with clinical stage III adenocarcinoma of the esophagus. Ann Thorac Surg 2004;77:1193-1199.
5. Slater MS, Holland J, Faigel DO, et al. Does neoadjuvant chemoradiation downstage esophageal carcinoma? Am J Surg 2001;181:440-444.
6. De Vita F, Di Martino N, Orditura M, et al. Preoperative chemoradiotherapy for squamous cell carcinoma and adenocarcinoma of the esophagus: a phase II study. Chest 2002;122:1302-1308.
7. Stahl M, Wilke H, Fink U, et al. Combined preoperative chemotherapy and radiotherapy in patients with locally advanced esophageal cancer: interim analysis of a phase II trial. J Clin Oncol 1996;14:829-837.
8. Schneider PM, Baldus SE, Metzger R, et al. Histomorphologic tumor regression and lymph node metastases determine prognosis following neoadjuvant radiochemotherapy for esophageal cancer: implications for response classification. Ann Surg 2005;242:684-692.
9. Forastiere AA, Orringer MB, Perez-Tamayo C, et al. Preoperative chemoradiation followed by transhiatal esophagectomy for carcinoma of the esophagus: final report. J Clin Oncol. 1993;11:1118-1123.
10. Tamin WZ, Davidson RS, Quinlan RM, et al. Neoadjuvant chemoradiotherapy for esophageal cancer: is it worthwhile? Arch Surg 1998;133:722-726.
11. Wolfe WG, Vaughn AL, Seigler HF, et al. Survival of patients with carcinoma of the esophagus treated with combined-modality therapy. J Thorac Cardiovasc Surg 1993;105:749-756.
12. Adelstein DJ, Rice TW, Becker M, et al. Use of concurrent chemotherapy, accelerated fractionation radiation, and surgery for patients with esophageal carcinoma. Cancer 1997;80:1011-1020.
13. Jones DR, Detterbeck FC, Egan TM, et al. Induction chemoradiotherapy followed by esophagectomy in patients with carcinoma of the esophagus. Ann Thorac Surg 1997;64:185-192.
14. Muller JM, Erasmi H, Stelzner M. Surgical therapy of oesophageal carcinoma. Br J Surg 1990;77:845-857.
15. Coia LR, Engstrom PF, Paul AR, et al. Long-term results of infusional 5-FU, mitomycin-C and radiation as primary management of esophageal carcinoma. Int J Radiat Oncol Biol Phys 1991;20:29-36.
16. Rizk NP, Venkatraman E, Bains MS, et al. American Joint Committee on Cancer staging system does not accurately predict survival in patients receiving multimodality therapy for esophageal adenocarcinoma. J Clin Oncol 2007;25:507-512.
17. Dunne B, Reynolds JV, Mulligan E, et al. A pathological study of tumor regression in oesophageal adenocarcinoma treated with preoperative chemoradiotherapy. J Clin Pathol 2001;54:841-845.
18. American Joint Committee on Cancer. FL Greene, DL Page, ID Fleming, et al (Eds). AJCC Cancer Staging Handbook. 6th Ed. New York: Springer-Verlag, 2002.
19. Breiman L, Friedman J, Stone CJ, et al. Classification and Regression Trees. New York: Chapman & Hall, 1984.
20. Lausen B, Schumacher M. Maximally selected rank statistics. Biometrics 1992;48:73-85.
21. Therneau TM, Atkinson EJ. Section of biostatistics. In: HSR Do (Ed.). An Introduction to Recursive Partitioning Using the RPART Routines. Rochester, MN: Mayo Clinic, 1997.
22. Ilson DH, Minsky B, Kelsen D. Irinotecan, cisplatin, and radiation in esophageal cancer. Oncology 2002;16(5 Suppl 5):11-15.
23. Renaud-Salis JL, Blanc-Vincent MP, BrigPre J, et al. Epidermoid cancers of the oropharynx. Br J Cancer 2001;84(Suppl 2):37-41.
24. Eng C. Anal cancer: current and future methodology. Cancer Invest 2006;24:535-544.
25. Bosset J-F, Gignoux M, Triboulet J-P, et al. Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med 1997;337:161-167.
26. Nygaard K, Hagen S, Hansen HS, et al. Pre-operative radiotherapy prolongs survival in operable esophageal carcinoma. A randomized, multicenter study of pre-operative radiotherapy and chemotherapy. The second Scandinavian trial in esophageal cancer. World J Surg 1992;16:1104-1110.
27. Le Prise E, Etienne PL, Meunier B, et al. A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus. Cancer 1994;73:1779-1784.
28. Seydel HG, Leichman L, Byhardt R, et al. Preoperative radiation and chemotherapy for localized squamous cell carcinoma of the esophagus: a RTOG study. Int J Radiat Oncol Biol Phys 1988;14:33-35.
29. Walsh TN, Noonan N, Hollywood D, et al. A comparison of multimodal therapy and surgery for esopahgeal adenocarcinoma. N Engl J Med 1996;335:462-467.